prenatal test

prenatal test

Obstetrics Any lab test or assay used to detect genetic and/or congenital fetal anomalies that would compromise the infant's well-being and quality of life to such a degree that the parents might prefer an abortion Examples α-fetoprotein levels in mother's serum or amniotic fluid, chromosome analysis, ultrasonography, chorionic villus biopsy–8th-10th gestational wks, risk of spontaneous abortion/miscarriage–1.0-1.5%, amniocentesis–16th gestational wk, risk of spontaneous abortion/miscarriage– 0.5%, fetoscopy, embryoscopy Diseases detected α1-antitrypsin activity, thalassemias, defects of sex and autosomal chromosomes, eg, trisomies, deletions, mosaicisms, fragile X syndrome, hemophilia, neural tube defects–anencephaly, spina bifida, polycystic kidney disease, Tay-Sachs disease. See Embroscopy, Fetoscopy. Cf Wrongful birth.
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.
References in periodicals archive ?
M2 PHARMA-August 20, 2014-LabCorp unveils InformaSeq Non-Invasive Prenatal Test in aid of diagnosis and care of patients
M2 PHARMA-August 19, 2014-LabCorp introduces InformaSeq non-invasive prenatal test
Following the acquisition, Illumina now has access to Verinata's verifi prenatal test and to the most comprehensive intellectual property portfolio in the NIPT industry.
M2 PHARMA-July 11, 2014-Natera gets CE marking for analytical software supporting Panorama prenatal test
M2 PHARMA-May 6, 2014-Ariosa gets New York State conditional clearance for Harmony prenatal test
28 April 2014 - US genetic variation and function analysis specialist Illumina Inc (NASDAQ:ILMN) said Friday it had submitted a new patent infringement lawsuit against US molecular diagnostics company Ariosa Diagnostics regarding the latter's Harmony prenatal test.
Natera announced results of a prospective validation study published in the Journal of Clinical Medicine demonstrating 100% accuracy of its Panorama non-invasive prenatal test in determining zygosity, fetal sex, and chromosomal abnormalities in twins as early as 9 weeks of gestation.
She explained that the test was 'a safe and accurate non-invasive prenatal test that can screen for some of the most common chromosomal abnormalities of an unborn child.
No prenatal test can predict the level of learning disability their child might have.
The new, non-invasive, prenatal test could save one to two babies from miscarriage each year
The new non-invasive prenatal test (NIPT) is expected to save one to two babies from miscarriage each year in Wales.